VAERS reports by lot

Merck HPV lot N023828: VAERS reports

50 VAERS reports list lot N023828 as a Merck HPV vaccine, received between 2018-04-06 and 2021-06-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
50
Reports
6%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2948%
Gastrointestinal1220%
General / Systemic (non-local)813%
Cardiac / Cardiovascular47%
Injection-site / Local reaction47%
Respiratory12%
Dermatological (non-injection-site)12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania10
Michigan9
New York8
Texas4
Maryland4
California4
Illinois3
Oregon1
Mississippi1
Washington1
Colorado1
Missouri1

Reports by month received

2018-041
2018-068
2018-079
2018-1016
2018-129
2019-021
2019-031
2019-041
2019-082
2020-091
2021-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.